Expanding the Nude SCID/CID Phenotype Associated with FOXN1 Homozygous, Compound Heterozygous, or Heterozygous Mutations.


Journal

Journal of clinical immunology
ISSN: 1573-2592
Titre abrégé: J Clin Immunol
Pays: Netherlands
ID NLM: 8102137

Informations de publication

Date de publication:
05 2021
Historique:
received: 21 07 2020
accepted: 06 01 2021
pubmed: 20 1 2021
medline: 21 1 2022
entrez: 19 1 2021
Statut: ppublish

Résumé

Human nude SCID is a rare autosomal recessive inborn error of immunity (IEI) characterized by congenital athymia, alopecia, and nail dystrophy. Few cases have been reported to date. However, the recent introduction of newborn screening for IEIs and high-throughput sequencing has led to the identification of novel and atypical cases. Moreover, immunological alterations have been recently described in patients carrying heterozygous mutations. The aim of this paper is to describe the extended phenotype associated with FOXN1 homozygous, compound heterozygous, or heterozygous mutations. We collected clinical and laboratory information of a cohort of 11 homozygous, 2 compound heterozygous, and 5 heterozygous patients with recurrent severe infections. All, except one heterozygous patient, had signs of CID or SCID. Nail dystrophy and alopecia, that represent the hallmarks of the syndrome, were not always present, while almost 50% of the patients developed Omenn syndrome. One patient with hypomorphic compound heterozygous mutations had a late-onset atypical phenotype. A SCID-like phenotype was observed in 4 heterozygous patients coming from the same family. A spectrum of clinical manifestations may be associated with different mutations. The severity of the clinical phenotype likely depends on the amount of residual activity of the gene product, as previously observed for other SCID-related genes. The severity of the manifestations in this heterozygous family may suggest a mechanism of negative dominance of the specific mutation or the presence of additional mutations in noncoding regions.

Identifiants

pubmed: 33464451
doi: 10.1007/s10875-021-00967-y
pii: 10.1007/s10875-021-00967-y
pmc: PMC8068652
doi:

Substances chimiques

Forkhead Transcription Factors 0
Whn protein 0

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

756-768

Subventions

Organisme : Medical Research Council
ID : MR/S036407/1
Pays : United Kingdom

Références

Pignata C, Fiore M, Guzzetta V, Castaldo A, Sebastio G, Porta F, et al. Congenital alopecia and nail dystrophy associated with severe functional T-cell immunodeficiency in two sibs. Am J Med Genet. 1996;65(2):167–70.
doi: 10.1002/(SICI)1096-8628(19961016)65:2<167::AID-AJMG17>3.0.CO;2-O
Frank J, Pignata C, Panteleyev AA, Prowse DM, Baden H, Weiner L, et al. Exposing the human nude phenotype. Nature. 1999;398(6727):473–4.
doi: 10.1038/18997
Gallo V, Cirillo E, Giardino G, Pignata C. FOXN1 deficiency: from the discovery to novel therapeutic approaches. J Clin Immunol. 2017;37(8):751–8.
doi: 10.1007/s10875-017-0445-z
Palamaro L, Romano R, Fusco A, Giardino G, Gallo V, Pignata C. FOXN1 in organ development and human diseases. Int Rev Immunol. 2014;33(2):83–93.
doi: 10.3109/08830185.2013.870171
Brissette JL, Li J, Kamimura J, Lee D, Dotto GP. The product of the mouse nude locus, Whn, regulates the balance between epithelial cell growth and differentiation. Genes Dev. 1996;10(17):2212–21.
doi: 10.1101/gad.10.17.2212
Lee D, Prowse DM, Brissette JL. Association between mouse nude gene expression and the initiation of epithelial terminal differentiation. Dev Biol. 1999;208(2):362–74.
doi: 10.1006/dbio.1999.9221
Kaufmann E, Knöchel W. Five years on the wings of fork head. Mech Dev. 1996;57(1):3–20.
doi: 10.1016/0925-4773(96)00539-4
Rota IA, Dhalla F. FOXN1 deficient nude severe combined immunodeficiency. Orphanet J Rare Dis. 2017;12(1):6.
doi: 10.1186/s13023-016-0557-1
Albuquerque AS, Marques JG, Silva SL, Ligeiro D, Devlin BH, Dutrieux J, et al. Human FOXN1-deficiency is associated with αβ double-negative and FoxP3+ T-cell expansions that are distinctly modulated upon thymic transplantation. PLoS One. 2012;7(5):e37042.
doi: 10.1371/journal.pone.0037042
Levy E, Neven B, Entz-Werle N, Cribier B, Lipsker D. Post-thymus transplant vitiligo in a child with Foxn1 deficiency. Ann Dermatol Venereol. 2012;139(6-7):468–71.
doi: 10.1016/j.annder.2012.03.014
Markert ML, Marques JG, Neven B, Devlin BH, McCarthy EA, Chinn IK, et al. First use of thymus transplantation therapy for FOXN1 deficiency (nude/SCID): a report of 2 cases. Blood. 2011;117(2):688–96.
doi: 10.1182/blood-2010-06-292490
Chou J, Massaad MJ, Wakim RH, Bainter W, Dbaibo G, Geha RS. A novel mutation in FOXN1 resulting in SCID: a case report and literature review. Clin Immunol. 2014;155(1):30–2.
doi: 10.1016/j.clim.2014.08.005
Radha Rama Devi A, Panday NN, Naushad SM. FOXN1 Italian founder mutation in Indian family: implications in prenatal diagnosis. Gene. 2017;627:222–5.
doi: 10.1016/j.gene.2017.06.033
Firtina S, Cipe F, Ng YY, Kiykim A, Ng OH, Sudutan T, et al. A novel FOXN1 variant is identified in two siblings with nude severe combined immunodeficiency. J Clin Immunol. 2019;39(2):144–7.
doi: 10.1007/s10875-019-00615-6
Albar R, Mahdi M, Alkeraithe F, Almufarriji KN. Epstein-Barr virus associated with high-grade B-cell lymphoma in nude severe combined immunodeficiency. BMJ Case Rep. 2019;12(5):e227715.
Pignata C, Gaetaniello L, Masci AM, Frank J, Christiano A, Matrecano E, et al. Human equivalent of the mouse nude/SCID phenotype: long-term evaluation of immunologic reconstitution after bone marrow transplantation. Blood. 2001;97(4):880–5.
doi: 10.1182/blood.V97.4.880
Bosticardo M, Yamazaki Y, Cowan J, Giardino G, Corsino C, Scalia G, et al. Heterozygous FOXN1 variants cause low TRECs and severe T cell lymphopenia, revealing a crucial role of FOXN1 in supporting early thymopoiesis. Am J Hum Genet. 2019;105(3):549–61.
doi: 10.1016/j.ajhg.2019.07.014
Du Q, Huynh LK, Coskun F, Molina E, King MA, Raj P, et al. FOXN1 compound heterozygous mutations cause selective thymic hypoplasia in humans. J Clin Invest. 2019;129(11):4724–38.
doi: 10.1172/JCI127565
Newman JA, Aitkenhead H, Gavard AE, Rota IA, Handel AE, Hollander GA, et al. The crystal structure of human forkhead box N1 in complex with DNA reveals the structural basis for forkhead box family specificity. J Biol Chem. 2020;295(10):2948–58.
doi: 10.1074/jbc.RA119.010365
Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem. 2004;25(13):1605–12.
doi: 10.1002/jcc.20084
Pires DE, Ascher DB, Blundell TL. mCSM: predicting the effects of mutations in proteins using graph-based signatures. Bioinformatics. 2014;30(3):335–42.
doi: 10.1093/bioinformatics/btt691
Peng Y, Sun L, Jia Z, Li L, Alexov E. Predicting protein-DNA binding free energy change upon missense mutations using modified MM/PBSA approach: SAMPDI webserver. Bioinformatics. 2018;34(5):779–86.
doi: 10.1093/bioinformatics/btx698
Lee MR, Duan Y, Kollman PA. Use of MM-PB/SA in estimating the free energies of proteins: application to native, intermediates, and unfolded villin headpiece. Proteins. 2000;39(4):309–16.
doi: 10.1002/(SICI)1097-0134(20000601)39:4<309::AID-PROT40>3.0.CO;2-S
Auricchio L, Adriani M, Frank J, Busiello R, Christiano A, Pignata C. Nail dystrophy associated with a heterozygous mutation of the nude/SCID human FOXN1 (WHN) gene. Arch Dermatol. 2005;141(5):647–8.
doi: 10.1001/archderm.141.5.647
Adriani M, Martinez-Mir A, Fusco F, Busiello R, Frank J, Telese S, et al. Ancestral founder mutation of the nude (FOXN1) gene in congenital severe combined immunodeficiency associated with alopecia in southern Italy population. Ann Hum Genet. 2004;68(Pt 3):265–8.
doi: 10.1046/j.1529-8817.2004.00091.x
Larsen BM, Cowan JE, Wang Y, Tanaka Y, Zhao Y, Voisin B, et al. Identification of an intronic regulatory element necessary for tissue-specific expression of Foxn1 in thymic epithelial cells. J Immunol. 2019;203(3):686–95.
doi: 10.4049/jimmunol.1801540
Tangye SG, Palendira U, Edwards ES. Human immunity against EBV-lessons from the clinic. J Exp Med. 2017;214(2):269–83.
doi: 10.1084/jem.20161846
Palendira U, Rickinson AB. Primary immunodeficiencies and the control of Epstein-Barr virus infection. Ann N Y Acad Sci. 2015;1356:22–44.
doi: 10.1111/nyas.12937
Tangye SG, Latour S. Primary immunodeficiencies reveal the molecular requirements for effective host defense against EBV infection. Blood. 2020;135(9):644–55.
doi: 10.1182/blood.2019000928
Notarangelo LD, Kim MS, Walter JE, Lee YN. Human RAG mutations: biochemistry and clinical implications. Nat Rev Immunol. 2016;16(4):234–46.
doi: 10.1038/nri.2016.28
Janda A, Sedlacek P, Honig M, Friedrich W, Champagne M, Matsumoto T, et al. Multicenter survey on the outcome of transplantation of hematopoietic cells in patients with the complete form of DiGeorge anomaly. Blood. 2010;116(13):2229–36.
doi: 10.1182/blood-2010-03-275966
Markert ML, Devlin BH, Chinn IK, McCarthy EA. Thymus transplantation in complete DiGeorge anomaly. Immunol Res. 2009;44(1-3):61–70.
doi: 10.1007/s12026-008-8082-5
Markert ML, Devlin BH, Alexieff MJ, Li J, McCarthy EA, Gupton SE, et al. Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants. Blood. 2007;109(10):4539–47.
doi: 10.1182/blood-2006-10-048652
Davies EG, Cheung M, Gilmour K, Maimaris J, Curry J, Furmanski A, et al. Thymus transplantation for complete DiGeorge syndrome: European experience. J Allergy Clin Immunol. 2017;140(6):1660–70.e16.
doi: 10.1016/j.jaci.2017.03.020

Auteurs

Giuliana Giardino (G)

Department of Translational Medical Sciences, Pediatrics Section, Federico II University of Naples, via S. Pansini 5, 80131, Naples, Italy.

Svetlana O Sharapova (SO)

Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.

Peter Ciznar (P)

Pediatric Department, Faculty of Medicine, Comenius University in Bratislava, National Institute of Childhood Diseases, Bratislava, Slovakia.

Fatima Dhalla (F)

Department of Paediatrics and the Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.

Luca Maragliano (L)

Center for Synaptic Neuroscience and Technology, Istituto Italiano di Tecnologia, 16132, Genova, Italy.

Akella Radha Rama Devi (A)

Sandor Life Sciences Pvt. Ltd., Banjara Hills, Hyderabad, India.

Candan Islamoglu (C)

Department of Pediatric Immunology and Allergy, Ankara University Medical School, Ankara, Turkey.

Aydan Ikinciogullari (A)

Department of Pediatric Immunology and Allergy, Ankara University Medical School, Ankara, Turkey.

Sule Haskologlu (S)

Department of Pediatric Immunology and Allergy, Ankara University Medical School, Ankara, Turkey.

Figen Dogu (F)

Department of Pediatric Immunology and Allergy, Ankara University Medical School, Ankara, Turkey.

Rima Hanna-Wakim (R)

Department of Pediatrics and Adolescent Medicine, American University of Beirut, Beirut, Lebanon.

Ghassan Dbaibo (G)

Department of Pediatrics and Adolescent Medicine, American University of Beirut, Beirut, Lebanon.

Janet Chou (J)

Division of Immunology, Boston Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA.

Emilia Cirillo (E)

Department of Translational Medical Sciences, Pediatrics Section, Federico II University of Naples, via S. Pansini 5, 80131, Naples, Italy.

Carla Borzacchiello (C)

Department of Translational Medical Sciences, Pediatrics Section, Federico II University of Naples, via S. Pansini 5, 80131, Naples, Italy.

Alexandra Y Kreins (AY)

Department of Paediatric Immunology, Great Ormond Street Hospital and UCL Great Ormond Street Institute of Child Health, London, UK.

Austen Worth (A)

Department of Paediatric Immunology, Great Ormond Street Hospital and UCL Great Ormond Street Institute of Child Health, London, UK.

Ioanna A Rota (IA)

Department of Paediatrics and the Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.

José G Marques (JG)

Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
Unidade de Infecciologia e Imunodeficiências, Departamento de Pediatria, Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal.

Muge Sayitoglu (M)

Department of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.

Sinem Firtina (S)

Faculty of Art and Science, Istinye University, Istanbul, Turkey.

Moaffaq Mahdi (M)

King Saud bin Abdulaziz University for Health Sciences College of Medicine, Jeddah, Saudi Arabia.

Raif Geha (R)

Division of Immunology, Boston Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA.

Bénédicte Neven (B)

Paediatric Haematology-Immunology and Rheumatology Department, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), Université de Paris, Institut IMAGINE, Paris, France.

Ana E Sousa (AE)

Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.

Fabio Benfenati (F)

Center for Synaptic Neuroscience and Technology, Istituto Italiano di Tecnologia, 16132, Genova, Italy.
IRCCS Ospedale Policlinico San Martino, 16132, Genova, Italy.

Georg A Hollander (GA)

Department of Paediatrics and the Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Paediatric Immunology, Department of Biomedicine, University of Basel, The Basel University Children's Hospital, 4052, Basel, Switzerland.

E Graham Davies (EG)

Department of Paediatric Immunology, Great Ormond Street Hospital and UCL Great Ormond Street Institute of Child Health, London, UK.

Claudio Pignata (C)

Department of Translational Medical Sciences, Pediatrics Section, Federico II University of Naples, via S. Pansini 5, 80131, Naples, Italy. pignata@unina.it.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH